Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations declare readOnlyHint=true, openWorldHint=true, idempotentHint=true, and destructiveHint=false, which cover safety and idempotency. The description goes well beyond: it discloses graceful degradation ('if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return'), ambiguous-match handling ('asserts nothing and returns figi_candidates'), unresolved-identifier handling ('stated explicitly under `unresolved` rather than omitted'), source labeling, and the internal cascading of lookup endpoints. These are behavioral traits an agent needs to predict output quality and failure modes, and none are in the schema or annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long (~350 words) but dense with actionable information. It is front-loaded with examples and the core use case, then organizes details by type, enrichment fallback, and input caveats. There is minimal fluff; nearly every sentence adds value. It slightly over-achieves in detail (e.g., the GLEIF ISIN-to-LEI mapping sentence), but this is warranted given the tool's complexity. A 4 is appropriate—comprehensive but not perfectly concise.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given there is no output schema and the tool is complex (multi-source cascade), the description is remarkably complete. It covers supported types, input formats, edge cases (ambiguous matches, unresolved IDs, non-equity instruments), degradation behavior, and the internal cascade. It even explains why certain inputs fail (trailing security-class words). An agent has everything it needs to invoke the tool correctly and interpret results, making this a model definition.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so parameter names/types are documented. But the description adds critical semantics: it warns to pass the entity name ONLY, not the full noun phrase (e.g., 'NEW YORK ST DORM AUTH' not 'NEW YORK ST DORM AUTH revenue bonds'), and explains why (FIGI lookup matches instrument names). It also clarifies accepted inputs for `value` (ticker, CIK, ISIN, name for company; brand/generic for drug) and the `type` enum values. This goes far beyond the schema's basic descriptions ('ticker (AAPL), CIK... or name').

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete example queries ('What's the ticker for…' / 'find the CIK for…'), then states the verb and resource precisely: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It explicitly lists supported types (company, drug) and the sources (SEC EDGAR, GLEIF, OpenFIGI, RxNorm). This clearly differentiates it from sibling tools like entity_profile or compare_entities, which operate on already-resolved entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit usage directive: 'Use FIRST whenever you have a name but need an ID.' This instructs when to invoke the tool and implies it is the entry point before other tools. It also explains that the tool replaces 2–3 manual lookups, reinforcing when it is the right choice. However, it does not explicitly mention alternatives or cases where one should NOT use it (e.g., when the entity ID is already known and one needs a profile), so it lacks explicit exclusion guidance but still provides clear context for when to use it.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.8/5.0
Disambiguation3/5

Several tools form tight families with overlapping purposes: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all handle research queries, and entity_profile/compare_entities/recent_changes aggregate overlapping data. The descriptions are thorough and do distinguish them, but an agent could easily select the wrong member of a family for a given query.

Naming Consistency3/5

Most tools use snake_case, but conventions vary: verb_noun (list_subscriptions, resolve_entity), domain-prefixed nouns (polymarket_arbitrage, coresignal_company), bare verbs (remember, forget, recall), and an ask_* family (ask_pipeworx, ask_pipeworx_grounded). Patterns are predictable within clusters but there is no uniform server-wide convention.

Tool Count2/5

33 tools is well beyond the comfortable range, and the server named 'Coresignal' carries only two Coresignal-branded tools while also hosting prediction-market analysis, memory utilities, npm dependency scanning, llms.txt generation, and feedback mechanisms. The breadth feels bloated even though the core research platform is substantial.

Completeness4/5

The research/QA domain is well covered: simple lookup, grounded verification, deep multi-source research, entity resolution and profiling, comparisons, claim validation, subscriptions, and memory. Meta-tools like discover_tools and suggest_questions help navigation. Minor gaps exist (e.g., no standalone bulk-download or export tool), but there are no obvious dead ends.